The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis

Wu, YF; Xu, JM; Du, CL; Wu, YH; Xia, DJ; Lv, W; Hu, J

Hu, J (reprint author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China.

FRONTIERS IN ONCOLOGY, 2019; 9 ():

Abstract

Background: Despite an increasing understanding about tumor mutation burden (TMB) in cancer immunity and cancer immunotherapy, the comprehensive cogni......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索